MD1004Y - Method for the treatment of infravesical obstruction caused by benign prostatic hyperplasia - Google Patents
Method for the treatment of infravesical obstruction caused by benign prostatic hyperplasia Download PDFInfo
- Publication number
- MD1004Y MD1004Y MDS20150054A MDS20150054A MD1004Y MD 1004 Y MD1004 Y MD 1004Y MD S20150054 A MDS20150054 A MD S20150054A MD S20150054 A MDS20150054 A MD S20150054A MD 1004 Y MD1004 Y MD 1004Y
- Authority
- MD
- Moldova
- Prior art keywords
- treatment
- benign prostatic
- prostatic hyperplasia
- obstruction caused
- infravesical obstruction
- Prior art date
Links
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 title abstract 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 abstract 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 abstract 2
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000011787 zinc oxide Substances 0.000 abstract 2
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 abstract 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 abstract 1
- 235000000832 Ayote Nutrition 0.000 abstract 1
- 235000009854 Cucurbita moschata Nutrition 0.000 abstract 1
- 240000001980 Cucurbita pepo Species 0.000 abstract 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 abstract 1
- 239000010476 amaranth oil Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000015136 pumpkin Nutrition 0.000 abstract 1
- 210000000664 rectum Anatomy 0.000 abstract 1
- 210000003932 urinary bladder Anatomy 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine, in particular to urology and can be used for the treatment of infravesical obstruction caused by benign prostatic hyperplasia.According to the invention, the method consists in that once a day, per rectum, through microclysters is administered in a volume of 30 ml an ozonated mixture based on pumpkin oil, obtained by cold pressing, which contains 5 mg of zinc oxide and silver nanoparticles, taken in the ratio of 9:1, with the ozone concentration of 9000 µg/L and 5 mg of a 5-alpha-reductase inhibitor, then after 2.5 hours is completely emptied the urinary bladder and instilled 150 ml of an ozonated mixture based on amaranth oil, obtained by cold pressing with the ozone concentration of 10000 µg/L, which contains 5 mg of zinc oxide and silver nanoparticles, taken in the ratio of 9:1, the treatment course is 40 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20150054A MD1004Z (en) | 2015-04-10 | 2015-04-10 | Method for the treatment of infravesical obstruction caused by benign prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20150054A MD1004Z (en) | 2015-04-10 | 2015-04-10 | Method for the treatment of infravesical obstruction caused by benign prostatic hyperplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1004Y true MD1004Y (en) | 2016-02-29 |
| MD1004Z MD1004Z (en) | 2016-09-30 |
Family
ID=55447198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20150054A MD1004Z (en) | 2015-04-10 | 2015-04-10 | Method for the treatment of infravesical obstruction caused by benign prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1004Z (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020125091A1 (en) * | 2018-12-19 | 2020-06-25 | 湖南中科文泰生物科技有限公司 | Sterol composition in pumpkin seed oil, application thereof, and drug for treating benign prostatic hyperplasia |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1159578A1 (en) * | 1981-06-22 | 1985-06-07 | Запорожский государственный институт усовершенствования врачей им.М.Горького | Method of treatment of prostate adenoma |
| SU1146066A1 (en) * | 1983-06-17 | 1985-03-23 | Центральный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Курортологии И Физиотерапии | Method of treatment of patients ill with prostate adenoma |
| SU1163859A1 (en) * | 1983-12-23 | 1985-06-30 | Министерство Здравоохранения Латвсср | Method of testing chronic prosthatite |
| MD482G2 (en) * | 1995-12-29 | 1997-05-31 | Firma Svetskii & Co | Continuous acted mixer |
| UA63883C2 (en) * | 1997-10-30 | 2004-02-16 | Петрушевський Іван Іванович | Massaging device for preventing and treating adenoma of prostate |
| MD2788G2 (en) * | 2004-07-28 | 2006-01-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Entomologic anti-inflammatory and antioxidant preparation |
| MD2952G2 (en) * | 2005-07-26 | 2006-08-31 | Валериу РУДИК | Medicinal remedy in the form of suppositories for prostatitis treatment |
| MD3426G2 (en) * | 2007-02-02 | 2008-10-31 | Виктор БОБУ | Urological draining device |
| UA32566U (en) * | 2007-12-06 | 2008-05-26 | Харьковская Медицинская Академия Последипломного Образования | Method for treatment of patients suffering from adenoma of prostate and chronic prostatitis |
| MD3804G2 (en) * | 2008-07-08 | 2009-09-30 | Виктор БОБУ | Method for endourethral drainage in urological lower floor organs operations |
| MD4025C2 (en) * | 2009-08-25 | 2010-10-31 | Владимир КАРАУШ | Remedy for treating prostatitis and prostate hyperplasia |
| RU2445000C2 (en) * | 2010-03-22 | 2012-03-20 | Общество с ограниченной ответственностью "ЭкоБиоФарм" | Method of diagnosing oncologic diseases of prostate gland on basis of acylcarnitine and arachidonoyl amine |
| RU2481847C2 (en) * | 2011-06-16 | 2013-05-20 | Государственное образовательное учреждение высшего профессионального образования "Дагестанская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию" | Method of treating suppurative septic complications of prostate adenoma |
| MD4296C1 (en) * | 2012-12-28 | 2015-03-31 | Вячеслав ЧУХРИЙ | Preparation from Tenebrio molitor larvae with antioxidant activity, process for its preparation and pharmaceutical product on its base |
-
2015
- 2015-04-10 MD MDS20150054A patent/MD1004Z/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020125091A1 (en) * | 2018-12-19 | 2020-06-25 | 湖南中科文泰生物科技有限公司 | Sterol composition in pumpkin seed oil, application thereof, and drug for treating benign prostatic hyperplasia |
Also Published As
| Publication number | Publication date |
|---|---|
| MD1004Z (en) | 2016-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4272818A3 (en) | Thrombolytic agent for the treatment of thromboembolism | |
| MX2019005533A (en) | Treatment for fibrosis. | |
| PH12021551455A1 (en) | Jak1 pathway inhibitors for the treatment of gastrointestinal disease | |
| CA3256605A1 (en) | Treating diseases using nitric oxide releasing solutions | |
| MX2019006193A (en) | Urogenital medical device formulation based on suitable biochemical compositions for the stabilization of the acidity and the redox state of the vaginal fluid. | |
| WO2015095834A3 (en) | Cancer treatments using erk1/2 and bcl-2 family inhibitors | |
| MX2022012079A (en) | METHODS AND COMPOSITIONS TO MAINTAIN KIDNEY HEALTH. | |
| MX2016015437A (en) | COMBINATION THAT INCLUDES A GLUCOCORTICOID AND EDO-S101. | |
| WO2010103291A3 (en) | Use of factor i for treating diseases involving the complement c3b feedback cycle | |
| MX354981B (en) | Medicine for treatment and/or improvement of sepsis. | |
| MX2021003651A (en) | Formulation comprising ozonised oil in the treatment of a tumour. | |
| MX390196B (en) | METHOD FOR MANUFACTURING A COMPOSITION COMPRISING A LOCAL ANESTHETIC, A HEPARINOID AND A PH REGULATOR. | |
| AU2017261919A1 (en) | Fat and medical uses thereof | |
| PH12019501439B1 (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
| WO2019043176A3 (en) | Hdac inhibitor in combination with antimetabolite agent for cancer therapy | |
| MD1004Y (en) | Method for the treatment of infravesical obstruction caused by benign prostatic hyperplasia | |
| PE20191793A1 (en) | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, INCLUDING PARACETAMOL, AND OPTIONALLY ONE OR MORE NSAIDS, AND A COMPOSITION OBTAINED FROM THE SAME | |
| SG10201808038TA (en) | Sildenafil Solutions and Methods of Making and Using Same | |
| NZ774649A (en) | Vibegron for the treatment of overactive bladder symptoms | |
| EP2786765A3 (en) | Composition for combination therapy comprising an anti-C-met antibody and a FGFR inhibitor | |
| WO2011091154A3 (en) | Use of human erythrocytes for prevention and treatment of cancer dissemination and growth | |
| EP3587392A8 (en) | Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases | |
| WO2020055906A8 (en) | Methods of treating cancer by inhibiting ubiquitin conjugating enzyme e2 k (ube2k) | |
| WO2019040499A3 (en) | Arf6 inhibitors and related methods | |
| MD774Y (en) | Endoscopic method for treating cirrhotic spontaneous ascites-peritonitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |